Defining optimal antithrombotic therapy post-TAVI: the contribution of ATLANTIS

Felicita Andreotti; Massimo Massetti; Jurrien Ten Berg

doi:10.1093/eurheartj/ehac139

Defining optimal antithrombotic therapy post-TAVI: the contribution of ATLANTIS

Felicita Andreotti, Massimo Massetti^*, Jurrien Ten Berg

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	2798-2800
Number of pages	3
Journal	European Heart Journal
Volume	43
Issue number	29
Early online date	18 May 2022
DOIs	https://doi.org/10.1093/eurheartj/ehac139
Publication status	Published - 1 Aug 2022

Keywords

SUBCLINICAL LEAFLET THROMBOSIS
TRANSCATHETER
VALVE THROMBOSIS

Access to Document

10.1093/eurheartj/ehac139

Cite this

@article{021e84ff11de42ff89257f3b7ab1d0e1,

title = "Defining optimal antithrombotic therapy post-TAVI: the contribution of ATLANTIS",

keywords = "SUBCLINICAL LEAFLET THROMBOSIS, TRANSCATHETER, VALVE THROMBOSIS",

author = "Felicita Andreotti and Massimo Massetti and {Ten Berg}, Jurrien",

year = "2022",

month = aug,

day = "1",

doi = "10.1093/eurheartj/ehac139",

language = "English",

volume = "43",

pages = "2798--2800",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "29",

}

TY - JOUR

T1 - Defining optimal antithrombotic therapy post-TAVI

T2 - the contribution of ATLANTIS

AU - Andreotti, Felicita

AU - Massetti, Massimo

AU - Ten Berg, Jurrien

PY - 2022/8/1

Y1 - 2022/8/1

KW - SUBCLINICAL LEAFLET THROMBOSIS

KW - TRANSCATHETER

KW - VALVE THROMBOSIS

U2 - 10.1093/eurheartj/ehac139

DO - 10.1093/eurheartj/ehac139

M3 - Editorial

C2 - 35583144

SN - 0195-668X

VL - 43

SP - 2798

EP - 2800

JO - European Heart Journal

JF - European Heart Journal

IS - 29

ER -